三友医疗
(688085)
| 流通市值：54.21亿 | | | 总市值：54.21亿 |
| 流通股本：2.48亿 | | | 总股本：2.48亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 332,733,558.44 | 212,076,101.08 | 86,429,306.35 | 460,392,060.81 |
| 营业收入 | 332,733,558.44 | 212,076,101.08 | 86,429,306.35 | 460,392,060.81 |
| 二、营业总成本 | 308,284,008.9 | 202,059,781.86 | 89,364,386.84 | 340,919,670.33 |
| 营业成本 | 100,892,751.12 | 67,597,144.37 | 36,041,938.87 | 92,302,988.28 |
| 税金及附加 | 4,304,992.03 | 2,725,436.71 | 1,051,167.09 | 6,008,896.8 |
| 销售费用 | 104,871,178.13 | 67,384,806.12 | 26,866,229.05 | 161,492,192.48 |
| 管理费用 | 39,868,862.29 | 25,493,755.25 | 12,059,522.88 | 31,984,152.04 |
| 研发费用 | 63,964,458.87 | 43,879,618.93 | 17,260,292.96 | 65,216,098.06 |
| 财务费用 | -5,618,233.55 | -5,020,979.52 | -3,914,764 | -16,084,657.33 |
| 其中:利息费用 | 1,218,456.31 | 667,039.23 | - | 268,094.43 |
| 其中:利息收入 | 8,614,366.22 | 7,219,770.46 | - | 16,254,737.22 |
| 加:公允价值变动收益 | -11,262.27 | 106,345.11 | - | 16,801,179.97 |
| 加:投资收益 | 818,929.61 | 864,777.09 | 1,140,226 | -22,700,474.23 |
| 资产处置收益 | -1,156.75 | -1,156.68 | -0.08 | 10,206.74 |
| 资产减值损失(新) | -13,696,156.65 | -9,015,005.99 | -2,101,337.02 | -12,492,736.55 |
| 信用减值损失(新) | -138,604.55 | 324,719.86 | 1,606,720.55 | 8,673,881.45 |
| 其他收益 | 3,840,739.55 | 3,030,850.25 | 777,264.37 | 10,661,638.7 |
| 营业利润平衡项目 | 0.01 | 0 | 0 | 0 |
| 四、营业利润 | 15,262,038.49 | 5,326,848.86 | -1,512,206.67 | 120,426,086.56 |
| 加:营业外收入 | 1,514,989.65 | 198,945.9 | 174,437.28 | 14,987,276.14 |
| 减:营业外支出 | 369,487.81 | 122,779.65 | 24,789.81 | 544,342.35 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 16,407,540.33 | 5,403,015.11 | -1,362,559.2 | 134,869,020.35 |
| 减:所得税费用 | 8,217,207.56 | 4,245,537.74 | 2,502,928.27 | 21,229,581.01 |
| 六、净利润 | 8,190,332.77 | 1,157,477.37 | -3,865,487.47 | 113,639,439.34 |
| 持续经营净利润 | 8,190,332.77 | 1,157,477.37 | -3,865,487.47 | 113,639,439.34 |
| 归属于母公司股东的净利润 | 8,570,582.96 | 1,676,137.43 | -2,095,834.44 | 95,582,882.73 |
| 少数股东损益 | -380,250.19 | -518,660.06 | -1,769,653.03 | 18,056,556.61 |
| (一)基本每股收益 | 0.03 | 0.01 | -0.01 | 0.38 |
| (二)稀释每股收益 | 0.03 | 0.01 | -0.01 | 0.38 |
| 八、其他综合收益 | 1,705,364.4 | 792,115.17 | -6,135,306.06 | 122,362.74 |
| 归属于母公司股东的其他综合收益 | 1,271,519.7 | 608,684.14 | -6,135,306.06 | 63,402.74 |
| 九、综合收益总额 | 9,895,697.17 | 1,949,592.54 | -10,000,793.53 | 113,761,802.08 |
| 归属于母公司股东的综合收益总额 | 9,842,102.66 | 2,284,821.57 | -8,231,140.5 | 95,646,285.47 |
| 归属于少数股东的综合收益总额 | 53,594.51 | -335,229.03 | -1,769,653.03 | 18,115,516.61 |
| 公告日期 | 2024-10-29 | 2024-08-28 | 2024-04-26 | 2024-04-26 |
| 审计意见(境内) | | | | 标准无保留意见 |